All Posts: clinical trials

32 Articles

News Release

Advanced Melanoma Survival Improves Significantly When Immunotherapy is Given Before Targeted Therapy

September 27, 2022

GUMC Stories

Glynda’s Story: A Chance to Advance Treatment for Aggressive Cancer

January 11, 2021

GUMC Stories

FDA Approves Lung Cancer Drug Supported by Georgetown Lombardi Research

September 14, 2020

GUMC Stories

Clinical Research Staff Rise to the Challenges Posed by Pandemic

(July 31, 2020) — Running clinical research can be complicated under normal circumstances but it’s especially arduous during a pandemic. Despite the difficulties, the…

July 31, 2020

GUMC Stories

First-of-Its-Kind Clinical Trial at Georgetown Puts Mammography Technologies Under the Spotlight

July 31, 2020

News Release

Nilotinib Appears Safe and Affects Biomarkers in Alzheimer’s Disease Clinical Trial

WASHINGTON (May 29, 2020) — A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer’s disease finds that it is…

May 29, 2020

News Release

Pressure to Endorse Use of Unproven Drugs for COVID-19 Threatens Public Confidence

WASHINGTON (April 16, 2020) — The widespread use of experimental treatments for COVID-19, including the antimalarial drugs chloroquine and hydroxychloroquine, represents “ill…

April 16, 2020

GUMC Stories

Georgetown Lombardi Clinical Trial Helps Advance Use of Immunotherapy in Liver Cancer

January 4, 2020

News Release

Nilotinib Appears Safe in Parkinson’s Trial; Drug Thought to Allow Dopamine Replenishment

WASHINGTON (December 16, 2019) — A clinical trial investigating the repurposed cancer drug nilotinib in people with Parkinson’s disease finds that it is reasonably safe and…

December 16, 2019

News Release

Nearly One-Quarter of Completed Lung Cancer Clinical Trial Results Are Not Published

November 6, 2019